Is a complete TNYA research report available?

No complete published report is available for Tenaya Therapeutics, Inc. (TNYA) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Tenaya Therapeutics, Inc. (TNYA)

NASDAQ: TNYA · USD

$0.79

-0.04 (-4.3%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-23 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first TNYA analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	171.2M
Revenue (ttm)	225K
Net income (ttm)	-83M
EPS (ttm)	-$0.46
Shares out	217M
Volume	1,371,514
Beta	2.84
Price target	$4.00	+407.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 225K
Net income (ttm): -83M
EPS (ttm): -$0.46
Market cap: 171.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All TNYA indicators

Market & fundamental data

Available fields

199

Groups with data

Currency

USD

Showing 199 of 199 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001858848
Company name	Tenaya Therapeutics, Inc.
Country	United States
Country code	US
Cusip	87990A106
Employees	70
Employees Change	-27%
Employees Change Percent	-27.84
Enterprise value	$101.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2021-07-30
Isin	US87990A1060
Last refreshed	2026-07-23
Market cap	$171.2M
Market cap category	Micro-Cap
Price	$0.79
Price currency	USD
Rev Per Employee	3,214.29x
Sector	Healthcare
Sector PE	44.74
Sector PE Fwd	23.64
Sic	2836
Symbol	TNYA
Website	https://www.tenayatherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-48.11%
EV Sales Forward	10.17x
EV/Sales	452.2x
FCF yield	-37.46%
P/B ratio	1.69x
P/S ratio	766.73x
PS Forward	17.25x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$225,000
Net Income	$-83M
Net Income Growth Quarters	8%
Net Income Growth Years	2%
Pretax Margin	-36,891.11%
Profit Per Employee	$-1.2M
ROA	-38.46
Roa5y	-35.25
ROCE	-72.58
ROE	-73.59
Roe5y	-65.31
ROIC	-43.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-7.9%
Cagr3y	-46.66%
EPS Growth Quarters	13
EPS Growth Years	5
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$135.1M
Cash	$80.9M
Current Assets	$96.6M
Current Liabilities	$16.8M
Debt	$10.1M
Debt Equity	$0.1
Equity	$106.2M
Liabilities	$28.9M
Long Term Assets	$38.5M
Long Term Liabilities	$12.1M
Net Cash	$70.8M
Net Cash By Market Cap	$41.02
Net Cash Growth	-5.95%
Net Debt Equity	$-0.67
Tangible Book Value	$106.2M
Tangible Book Value Per Share	$0.49
WACC	18.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.75
Net Working Capital	$2M
Quick ratio	5.45
Working Capital	$79.8M
Working Capital Turnover	$0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-95.26%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-7.89%
200-day SMA	0.94
3Y total return	-84.83%
50-day SMA	0.8
50-day SMA vs 200-day SMA	50under200
All Time High	32
All Time High Change	-97.53%
All Time High Date	2021-11-08
All Time Low	0.36
All Time Low Change	119.17%
All Time Low Date	2025-05-13
ATR	0.06
Beta	2.84
Beta1y	2.17
Beta2y	2.83
Ch YTD	10.89
High	0.83
High52	2.35
High52 Date	2025-10-10
High52ch	-66.43%
Low	0.79
Low52	0.53
Low52 Date	2026-03-03
Low52ch	48.42%
Ma50ch	-1.02%
Premarket Change Percent	0.65
Premarket Price	$0.83
Premarket Volume	10,414
Price vs 200-day SMA	-16.24%
RSI	47.61
RSI Monthly	40.41
RSI Weekly	48.38
Sharpe ratio	0.42x
Sortino ratio	0.72
Total Return	-95.26%
Tr YTD	10.89
Tr1m	7.99%
Tr1w	-6.43%
Tr3m	13.85%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	8
Analyst Count Top	6
Analyst Price Target Top	$12
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.07
Earnings Revenue Estimate	10,000,000x
Operating Income	$-85.9M
Operating margin	-38,159.1
Price target	$4
Price Target Change	$407
Price Target Change Top	$1,421

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	216,071,866%
Float Percent	99.57%
Shares Insiders	0.43%
Shares Institutions	25.07%
Shares Out	216,998,876
Shares Qo Q	23.9%
Shares Yo Y	95.26%
Short Float	12.14%
Short Ratio	9.42
Short Shares	12.09

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-76.1M
Average Volume	2,444,740.35x
Bv Per Share	0.49
CAPEX	$-246,000
Ch1m	7.99
Ch1w	-6.43
Ch1y	-7.89
Ch3m	13.85
Ch3y	-84.83
Ch6m	10.21
Change	-4.32%
Change From Open	-3.78
Close	0.82
Days Gap	-0.56
Depreciation Amortization	7,538,000
Dollar Volume	1,082,124.5
Earnings Date	2026-08-06
Earnings Time	amc
EBIT	$-85.9M
EBITDA	$-78.3M
EPS	$-0.46
F Score	1
FCF	$-64.6M
FCF EV Yield	-63.52x
FCF Per Share	$-0.3
Financing CF	57,731,000
Fiscal Year End	December
Founded	2,016
Investing CF	33,770,000
Ipr	-94.7
Iprfo	-95.92
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-11
Ma150	0.76
Ma150ch	4.43%
Ma20	0.81
Ma20ch	-2.48%
Net CF	27,115,000
Next Earnings Date	2026-08-05
Open	0.82
Optionable	Yes
Position In Range	9.01
Post Close	0.79
Postmarket Change Percent	0.22
Postmarket Price	$0.79
Ppne	34,723,000
Pre Close	0.82
Price Date	2026-07-22
Ptbv Ratio	1.62
Relative Volume	0.56x
Revenue	225,000x
SBC By Revenue	5,116x
Share Based Comp	11,511,000
Tr6m	10.21%
Us State	California
Volume	1,371,514
Z Score	-4.53

Tenaya Therapeutics, Inc. (TNYA)

Coverage state: Market snapshot only — no published research

Generate the first TNYA analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · TNYA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TNYA indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on TNYA

Frequently asked questions